Total Payments
$16,020
2024 Payments
$1,959
Companies
46
Transactions
726
Medicare Patients
6,408
Medicare Billing
$474,871
Payment Breakdown by Category
Food & Beverage$14,310 (89.3%)
Travel$1,553 (9.7%)
Education$157.14 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,310 | 715 | 89.3% |
| Travel and Lodging | $1,553 | 3 | 9.7% |
| Education | $157.14 | 8 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $5,542 | 126 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,537 | 114 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,478 | 77 | $0 (2024) |
| Amgen Inc. | $1,138 | 56 | $0 (2024) |
| PFIZER INC. | $712.06 | 52 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $578.33 | 34 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $570.20 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $542.06 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $533.56 | 24 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $469.35 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,959 | 89 | BIOTRONIK INC. ($510.19) |
| 2023 | $1,588 | 84 | BIOTRONIK INC. ($318.46) |
| 2022 | $1,698 | 99 | BIOTRONIK INC. ($409.71) |
| 2021 | $904.97 | 41 | BIOTRONIK INC. ($338.30) |
| 2020 | $1,023 | 59 | BIOTRONIK INC. ($266.24) |
| 2019 | $2,438 | 118 | BIOTRONIK INC. ($436.25) |
| 2018 | $2,001 | 114 | BIOTRONIK INC. ($580.83) |
| 2017 | $4,408 | 122 | BIOTRONIK INC. ($2,682) |
All Payment Transactions
726 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $2.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $37.89 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Genetic Disease | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.85 | General |
| Category: Cardiovascular | ||||||
| 12/02/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | BIOTRONIK INC. | NHancer Rx (Device), Orsiro Mission | Food and Beverage | In-kind items and services | $38.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/04/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.99 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Not Applicable | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | BIOTRONIK INC. | Acticor 7 VR-T DX (Device) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/02/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $77.89 | General |
| Category: Structural Heart | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,527 | 2,233 | $474,228 | $109,023 |
| 2022 | 21 | 1,576 | 2,235 | $551,896 | $124,588 |
| 2021 | 19 | 1,485 | 2,008 | $501,951 | $116,528 |
| 2020 | 19 | 1,820 | 2,484 | $590,076 | $124,732 |
Total Patients
6,408
Total Services
8,960
Medicare Billing
$474,871
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 404 | 632 | $231,944 | $52,095 | 22.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 122 | $38,064 | $11,113 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 65 | $33,475 | $7,157 | 21.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 42 | 42 | $23,604 | $5,770 | 24.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 79 | 80 | $15,360 | $3,852 | 25.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 59 | 147 | $12,642 | $3,047 | 24.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $18,297 | $2,969 | 16.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 77 | 191 | $12,224 | $2,939 | 24.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $9,840 | $2,415 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $10,059 | $2,288 | 22.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 49 | 49 | $11,662 | $2,229 | 19.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 12 | $7,404 | $1,983 | 26.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $9,105 | $1,858 | 20.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 238 | 315 | $8,167 | $1,623 | 19.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 13 | 85 | $6,460 | $1,472 | 22.8% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 18 | 44 | $4,664 | $1,096 | 23.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 107 | 110 | $4,620 | $1,019 | 22.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 12 | 13 | $4,043 | $991.87 | 24.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 12 | $2,592 | $734.04 | 28.3% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 17 | 17 | $2,651 | $608.00 | 22.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 84 | 87 | $2,088 | $515.78 | 24.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 53 | 53 | $2,332 | $444.10 | 19.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 38 | 39 | $1,443 | $367.08 | 25.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 16 | 18 | $774.00 | $257.22 | 33.2% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 21 | 21 | $714.00 | $179.73 | 25.2% |
About Dr. Michael Liston, MD
Dr. Michael Liston, MD is a Cardiovascular Disease healthcare provider based in Blue Springs, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093735557.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Liston, MD has received a total of $16,020 in payments from pharmaceutical and medical device companies, with $1,959 received in 2024. These payments were reported across 726 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($14,310).
As a Medicare-enrolled provider, Liston has provided services to 6,408 Medicare beneficiaries, totaling 8,960 services with total Medicare billing of $474,871. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Blue Springs, MO
- Active Since 07/20/2006
- Last Updated 11/17/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1093735557
Products in Payments
- XARELTO (Drug) $1,478
- ENTRESTO (Drug) $1,176
- ELIQUIS (Drug) $864.81
- Repatha (Biological) $596.65
- Corlanor (Drug) $541.10
- BIOMONITOR (Device) $533.80
- VERQUVO (Drug) $514.23
- BRILINTA (Drug) $484.21
- MULTAQ (Drug) $397.86
- LEQVIO (Drug) $361.29
- JARDIANCE (Drug) $310.98
- LifeVest (Device) $288.70
- Orsiro Mission (Device) $269.68
- PRADAXA (Drug) $241.16
- VYNDAQEL (Drug) $204.73
- CHANTIX (Drug) $167.63
- NHancer Rx (Device) $165.40
- Ranexa (Drug) $161.22
- CoreValve Evolut (Device) $153.77
- WATCHMAN (Device) $145.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.